RDF/XMLNTriplesTurtleShow queryShare
SubjectPredicateObject
http://purl.uniprot.org/citations/34467254http://www.w3.org/1999/02/22-rdf-syntax-ns#typehttp://purl.uniprot.org/core/Journal_Citation
http://purl.uniprot.org/citations/34467254http://www.w3.org/2000/01/rdf-schema#comment"Anti-integrins are therapeutically effective for inflammatory bowel disease, yet the relative contribution of α4β7 and αEβ7 to gut lymphocyte trafficking is not fully elucidated. Here, we evaluate the effect of α4β7 and αEβ7 blockade using a combination of murine models of gut trafficking and longitudinal gene expression analysis in etrolizumab-treated patients with Crohn's disease (CD). Dual blockade of α4β7 and αEβ7 reduces CD8+ T cell accumulation in the gut to a greater extent than blockade of either integrin alone. Anti-αEβ7 reduces epithelial:T cell interactions and promotes egress of activated T cells from the mucosa into lymphatics. Inflammatory gene expression is greater in human intestinal αEβ7+ T cells. Etrolizumab-treated patients with CD display a treatment-specific reduction in inflammatory and cytotoxic intraepithelial lymphocytes (IEL) genes. Concurrent blockade of α4β7 and αEβ7 promotes reduction of cytotoxic IELs and inflammatory T cells in the gut mucosa through a stepwise inhibition of intestinal tissue entry and retention."xsd:string
http://purl.uniprot.org/citations/34467254http://purl.org/dc/terms/identifier"doi:10.1016/j.xcrm.2021.100381"xsd:string
http://purl.uniprot.org/citations/34467254http://purl.uniprot.org/core/author"Nguyen A."xsd:string
http://purl.uniprot.org/citations/34467254http://purl.uniprot.org/core/author"Yi T."xsd:string
http://purl.uniprot.org/citations/34467254http://purl.uniprot.org/core/author"Scherl A."xsd:string
http://purl.uniprot.org/citations/34467254http://purl.uniprot.org/core/author"Dai B."xsd:string
http://purl.uniprot.org/citations/34467254http://purl.uniprot.org/core/author"Modrusan Z."xsd:string
http://purl.uniprot.org/citations/34467254http://purl.uniprot.org/core/author"Ichikawa R."xsd:string
http://purl.uniprot.org/citations/34467254http://purl.uniprot.org/core/author"Oh Y.S."xsd:string
http://purl.uniprot.org/citations/34467254http://purl.uniprot.org/core/author"McBride J."xsd:string
http://purl.uniprot.org/citations/34467254http://purl.uniprot.org/core/author"Sun K.H."xsd:string
http://purl.uniprot.org/citations/34467254http://purl.uniprot.org/core/author"Elstrott J."xsd:string
http://purl.uniprot.org/citations/34467254http://purl.uniprot.org/core/author"Habtezion A."xsd:string
http://purl.uniprot.org/citations/34467254http://purl.uniprot.org/core/author"Hackney J.A."xsd:string
http://purl.uniprot.org/citations/34467254http://purl.uniprot.org/core/author"Chai A."xsd:string
http://purl.uniprot.org/citations/34467254http://purl.uniprot.org/core/author"Gogineni A."xsd:string
http://purl.uniprot.org/citations/34467254http://purl.uniprot.org/core/author"Faubion W.A."xsd:string
http://purl.uniprot.org/citations/34467254http://purl.uniprot.org/core/author"Tole S."xsd:string
http://purl.uniprot.org/citations/34467254http://purl.uniprot.org/core/author"Hassanali A."xsd:string
http://purl.uniprot.org/citations/34467254http://purl.uniprot.org/core/author"Somsouk M."xsd:string
http://purl.uniprot.org/citations/34467254http://purl.uniprot.org/core/author"Keir M.E."xsd:string
http://purl.uniprot.org/citations/34467254http://purl.uniprot.org/core/author"Orozco L.D."xsd:string
http://purl.uniprot.org/citations/34467254http://purl.uniprot.org/core/author"Deswal M."xsd:string
http://purl.uniprot.org/citations/34467254http://purl.uniprot.org/core/author"Gubatan J."xsd:string